Pneumocystis jirovecii pneumonia detection and treatment
Pneumocystis jirovecii pneumonia detection and treatment is a research topic within Epidemiology. Science Explorer counts 32k research works in it since 1950. 14.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, pathogenesis, diagnosis, and treatment of Pneumocystis pneumonia, particularly in the context of HIV infection and immunocompromised patients. It covers topics such as opportunistic infections, colonization by Pneumocystis, impact of antiretroviral therapy, and the clinical significance of Pneumocystis colonization.
- Pneumocystis
- Pneumonia
- HIV
- Opportunistic Infections
- Antiretroviral Therapy
- Colonization
- Diagnosis
- Treatment
- Immunocompromised Patients
- Epidemiology
- Research works
- 32k fractional, since 1950
- In the world top 10%
- 4.5k per year above
- Top-10% rate
- 14.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +15% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Pneumocystis jirovecii pneumonia detection and treatment research?
By volume, the United States and China publish the most (1k and 575 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1k works
- 2 China 575 works
- 3 India 320 works
- 4 Japan 172 works
- 5 France 161 works
- 6 United Kingdom 160 works
- 7 Spain 147 works
- 8 Germany 119 works
- 9 Brazil 112 works
- 10 Italy 111 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Pneumocystis jirovecii pneumonia detection and treatment research?
By volume in 2022–2025, Johns Hopkins University publishes the most Pneumocystis jirovecii pneumonia detection and treatment research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and University of North Carolina at Chapel Hill.
By volume, 2022–2025
- 1 Johns Hopkins UniversityUnited States 17 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 15 works
- 3 University of North Carolina at Chapel HillUnited States 14 works
- 4 The University of Texas MD Anderson Cancer CenterUnited States 13 works
- 5 Capital Medical UniversityChina 13 works
- 6 University of Cape TownSouth Africa 12 works
- 7 University of the WitwatersrandSouth Africa 12 works
- 8 Emory UniversityUnited States 12 works
- 9 InsermFrance 11 works
- 10 Post Graduate Institute of Medical Education and ResearchIndia 11 works
Who are the leading researchers in Pneumocystis jirovecii pneumonia detection and treatment?
The most-cited researchers publishing on Pneumocystis jirovecii pneumonia detection and treatment include Hagop M. Kantarjian.
- 1 Hagop M. Kantarjian United States 4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Pneumocystis jirovecii pneumonia detection and treatment research done?
The largest centres of Pneumocystis jirovecii pneumonia detection and treatment research in 2022–2025 are Beijing (China), London (United Kingdom), Paris (France) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Kampala.
Largest cities, 2022–2025
Where it is the local speciality
- KampalaUG · 25.6 works14×
Location quotient: how much more of its research is in Pneumocystis jirovecii pneumonia detection and treatment than the world average.
Where is the best place to study Pneumocystis jirovecii pneumonia detection and treatment?
Among universities, judged by research, University of Cape Town, University of the Witwatersrand and Makerere University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of Cape TownSouth Africa | 69.1 | 20.7% | 9.0× | 12 | +10.8% |
| 2 | University of the WitwatersrandSouth Africa | 56.2 | 17.9% | 6.7× | 12 | +15.8% |
| 3 | Makerere UniversityUganda | 54.4 | 12.6% | 12.6× | 10 | +1.1% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 51.8 | 14.9% | 3.7× | 15 | +80.2% |
| 5 | Johns Hopkins UniversityUnited States | 49.2 | 15.8% | 3.8× | 17 | -9.1% |
| 6 | Capital Medical UniversityChina | 48.8 | 14.6% | 5.2× | 13 | +59.1% |
| 7 | Emory UniversityUnited States | 46.5 | 18.4% | 4.0× | 12 | +34.4% |
| 8 | Harvard UniversityUnited States | 45.5 | 25.9% | 1.8× | 9 | +4.2% |
| 9 | KU LeuvenBelgium | 41.8 | 23.2% | 2.2× | 8 | +0.9% |
| 10 | Yale UniversityUnited States | 41.7 | 17.6% | 2.1× | 9 | +105.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Pneumocystis jirovecii pneumonia detection and treatment research growing?
Output in 2018–2022 was 15% higher than in 2013–2017, peaking in 2020. The fastest-growing topics are Pneumocystis jirovecii pneumonia detection and treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.